New cancer clinical trial: First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

Published on: March 01, 2018 at 12:00PM
Condition:   Elderly Metastatic Colorectal Cancer Patients
Interventions:   Drug: Capecitabine;   Drug: Oxaliplatin;   Drug: Bevacizumab
Sponsor:   Istituto Oncologico Veneto IRCCS
Recruiting
http://ift.tt/2FitdCU